drugset / Trial / NCT04175301
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a pilot randomized control trial (RCT) to explore the effects of hydrogen rich water on quality of life in patients with high grade gliomas, receiving focal radiation therapy to the brain concurrent with chemotherapy with Temozolomide.
Timeline
- Start
- 2019-10-31
- Primary completion
- 2026-09-05
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrogen | Unknown | 1.6 ppm | Oral |